These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1682519)
1. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis. Tamura G; Maesawa C; Mikawa S; Satodate R Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer. Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma. Freeman JW; McGrath P; Bondada V; Selliah N; Ownby H; Maloney T; Busch RK; Busch H Cancer Res; 1991 Apr; 51(8):1973-8. PubMed ID: 1672621 [TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Wilbur DC; Barrows GH Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay. Narita T; Funahashi H; Satoh Y; Imai T; Takagi H Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994 [TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer. Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508 [TBL] [Abstract][Full Text] [Related]
8. C-erbB-2 protein and neuroendocrine expression in breast carcinomas. Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329 [TBL] [Abstract][Full Text] [Related]
9. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer. Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry. Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685 [TBL] [Abstract][Full Text] [Related]
11. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry. Li BD; Bauer KD; Carney WP; Duda RB J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635 [TBL] [Abstract][Full Text] [Related]
12. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast. Lilleng R; Hagmar BM; Nesland JM Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer. Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation. Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161 [TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 amplification in node-negative human breast cancer. Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424 [TBL] [Abstract][Full Text] [Related]
16. Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometry. Kelsten ML; Berger MS; Maguire HC; Chianese DA; Hellman ME; Weiner DB; Greene MI Cytometry; 1990; 11(4):522-32. PubMed ID: 2188818 [TBL] [Abstract][Full Text] [Related]
17. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663 [TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer. Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341 [TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. Heintz NH; Leslie KO; Rogers LA; Howard PL Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]